Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

PharmaCyte Biotech (PMCB) Return on Assets (2016 - 2026)

PharmaCyte Biotech (PMCB) has disclosed Return on Assets for 16 consecutive years, with 0.08% as the latest value for Q1 2026.

  • Quarterly Return on Assets rose 1.0% to 0.08% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.08% through Jan 2026, up 1.0% year-over-year, with the annual reading at 0.05% for FY2025, 3.0% up from the prior year.
  • Return on Assets for Q1 2026 was 0.08% at PharmaCyte Biotech, down from 0.07% in the prior quarter.
  • The five-year high for Return on Assets was 0.04% in Q4 2023, with the low at 0.09% in Q1 2025.
  • Average Return on Assets over 5 years is 0.06%, with a median of 0.06% recorded in 2025.
  • The sharpest move saw Return on Assets surged 48bps in 2022, then fell -5bps in 2025.
  • Over 5 years, Return on Assets stood at 0.07% in 2022, then surged by 47bps to 0.04% in 2023, then tumbled by -119bps to 0.08% in 2024, then increased by 15bps to 0.07% in 2025, then decreased by -23bps to 0.08% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.08%, 0.07%, and 0.06% for Q1 2026, Q4 2025, and Q3 2025 respectively.